Before Angelina Jolie told the world about her decision to have a double mastectomy, you might not have heard of BRCA1 or BRCA2. These are two genes where mutations are known to increase a woman’s risk of breast cancer. Jolie’s health risk was raised because of a mutation of the BRCA1 gene.
Scientists say we need to look beyond BRCA – to other genes that also increase a woman’s risk of breast cancer. KERA’s Lauren Silverman talks with Linda Robinson, assistant director of the Cancer Genetics Program at UT Southwestern about the future of genetic testing for breast cancer.